Development of a treatment regimen for human cytomegalovirus (CMV) infection in bone marrow transplantation recipients by adoptive transfer of donor-derived CMV-specific T cell clones expanded in vitro.
about
CMV-Specific CD8 T Cell Differentiation and Localization: Implications for Adoptive TherapiesCytomegalovirus as a cause of pancytopenia.The pathogenicity of cytomegalovirus.Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant.Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient miceIdentification, analysis, and evolutionary relationships of the putative murine cytomegalovirus homologs of the human cytomegalovirus UL82 (pp71) and UL83 (pp65) matrix phosphoproteins.Cytomegalovirus following stem cell transplantation: from pharmacologic to immunologic therapy.Targeting cytomegalovirus-infected cells using T cells armed with anti-CD3 × anti-CMV bispecific antibody.Parameters determining the efficacy of adoptive CD8 T-cell therapy of cytomegalovirus infection.CAR-modified anti-CD19 T cells for the treatment of B-cell malignancies: rules of the road.Adoptive immunotherapy for cancer.Refining human T-cell immunotherapy of cytomegalovirus disease: a mouse model with 'humanized' antigen presentation as a new preclinical study tool.Target structures of the CD8(+)-T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited.Varicella-Zoster Virus-Specific Cellular Immune Responses to the Live Attenuated Zoster Vaccine in Young and Older Adults.Viral infections in leukemia and bone marrow transplant patients.Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation.Adoptive T-cell immunotherapy from third-party donors: characterization of donors and set up of a T-cell donor registry.Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation.Subclinical activation of latent cytomegalovirus (CMV) infection and anti-CMV immune response in patients with atopic dermatitis.A high prevalence of cytomegalovirus antigenaemia in patients with moderate to severe chronic plaque psoriasis: an association with systemic tumour necrosis factor alpha overexpression.Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantation
P2860
Q28073770-07CAD2F0-90F7-44D5-B3F7-F4AEBA91BF4FQ33496395-CFD760C2-67F2-414E-A7A5-4BC4C297ACE0Q33697113-D9F7BF27-917C-464B-BF77-DC02F7C658C5Q34102747-003B2664-D6C2-4599-9E72-8BD17F678163Q34667739-9808BEC4-7907-4B99-A39D-F18A1AE6DACDQ35872401-2FE6AFFD-A4AB-4585-A9D3-19392DB8D02EQ35917480-4362D721-5EC8-41BD-ADCA-7E89F266BF1BQ37220602-E11D6E70-944F-4DCB-87FF-7012DED3C704Q38042835-6173DD24-B496-4906-9FDB-21431DBADCEEQ38164792-5BEE46C0-D875-45FC-9EFD-70700356B76AQ38170496-C900375A-31ED-4D31-87F6-DCD78E7ED4BAQ38931391-EF61CB2D-C064-4435-A690-67420FAB0379Q39595809-6EAC7DBB-B0AE-43A5-B811-1532D2305946Q40162587-C9312297-4F4C-4647-95C6-887EAE358111Q40722959-3D6370FB-3915-47D5-BE14-7135211F32F8Q42176262-7A61F1C4-FDB8-4060-9CE4-B6CB8A409B63Q42271011-7527E861-D04C-4508-A201-C049F529321BQ43406230-06FF7B30-815F-48C6-9D3E-C8EB53ABBFE1Q47861289-B0EB765A-6521-42F5-8F87-D2AB2B9F24F7Q52978117-10A0FE74-544F-4979-83E2-0F2E2B10D0D7Q57083246-6665F534-6938-47FC-A4CE-FC24297D0C3A
P2860
Development of a treatment regimen for human cytomegalovirus (CMV) infection in bone marrow transplantation recipients by adoptive transfer of donor-derived CMV-specific T cell clones expanded in vitro.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Development of a treatment reg ...... cell clones expanded in vitro.
@en
Development of a treatment regimen for human cytomegalovirus
@nl
type
label
Development of a treatment reg ...... cell clones expanded in vitro.
@en
Development of a treatment regimen for human cytomegalovirus
@nl
prefLabel
Development of a treatment reg ...... cell clones expanded in vitro.
@en
Development of a treatment regimen for human cytomegalovirus
@nl
P2093
P2860
P1476
Development of a treatment reg ...... cell clones expanded in vitro.
@en
P2093
J M Goodrich
P D Greenberg
S R Riddell
P2860
P304
P356
10.1111/J.1749-6632.1991.TB33450.X
P407
P577
1991-12-01T00:00:00Z